CHRISTOPHER L MOERTEL MD
Prescription History 1720058043
Pediatrics - Pediatric Hematology-Oncology in Minneapolis, MN
Quality Rating: 81.72 out of 100 score
NPI Status: Active since January 26, 2006
Contact Information
2450 RIVERSIDE AVE.
EAST BUILDING, NINTH FLOOR
MINNEAPOLIS, MN
ZIP 55454
Phone: (612) 365-8100
Fax: (651) 220-6005
Prescription History for Informed Healthcare Decisions
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for CHRISTOPHER L MOERTEL MD, an active Pediatric Hematology-Oncology specialist practicing in Minneapolis, MN. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 25 documented patient claims. Among these therapy options, the most frequently utilized medication is Mekinist, which accounts for 13 claims alone.
Koselugo
Generic Formulation: Selumetinib/Vitamin E TpgsSpecialty: Pediatric MedicineProvider Avg Cost Per Claim
$9,678.84
State Avg Cost Per Claim
$11,486.80
Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.
Selumetinib is used to treat a type of tumor that grows on nerves (neurofibromatosis type 1). Selumetinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of tumor cells.
Mekinist
Generic Formulation: Trametinib Dimethyl SulfoxideSpecialty: Pediatric MedicineProvider Avg Cost Per Claim
$9,836.21
State Avg Cost Per Claim
$14,421.73
Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.
Trametinib is used to treat various cancers (such as skin, thyroid, lung, solid tumors). It belongs to a class of drugs known as kinase inhibitors. Trametinib works by slowing or stopping the growth of cancer cells.
Dataset Methodology & CMS Source Information
This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like CHRISTOPHER L MOERTEL MD provides transparency into local medical care patterns within Minneapolis, MN.
Key Learning Objectives for this Profile:
- Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
- Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pediatric Hematology-Oncology** practice concentrations.
- Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
- Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.
Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.
